Zurex Pharma Inc., a Baird Capital Portfolio company, has raised $9 million ahead of its pending New Drug Application submission and review by the U.S. Food and Drug Administration for its first product, ZurexPrep.
The positive employment report released by the Bureau of Labor Statistics last month shows good news for the economy, but one investment strategist is delving into the details of the report and its potential impact on economy.
Although the U.S. economy has made strong gains over the past few months in manufacturing with low unemployment, the tightening of the labor market for the second half of the year could prevent that growth from getting much bigger, several Raymond James financial professionals suggest.
This year’s first quarter witnessed significant findings regarding Australian investors’ expectations about Artificial Intelligence (AI) technologies geared specifically for institutional financial services, Northern Trust revealed from its Chicago-area hub recently.
Sealing an agreement between their respective firms, representatives from Principal Financial Group and ASEAN investment bank CIMB Group recently passed all regulatory requirements and inked a deal to create a joint venture in asset management.
In a recent Morgan Stanley wealth management blog, senior market strategist Scott Helfstein says developments in AI are sure to have an impact on business so it's important to know how to invest in this area.
A recent ruling by the Danish National Tax Board will allow Denmark's institutional investors to benefit from dual taxation treaties and allows access to Northern Trust Asset Management's Common Contractural Fund.